Biomimetic delivery of signals for bone tissue engineering

被引:176
作者
Dang, Ming [1 ]
Saunders, Laura [1 ]
Niu, Xufeng [2 ,3 ]
Fan, Yubo [2 ,3 ]
Ma, Peter X. [1 ,4 ,5 ,6 ]
机构
[1] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA
[2] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China
[3] Beihang Univ, Beijing Adv Innovat Ctr Biomed Engn, Beijing, Peoples R China
[4] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA
来源
BONE RESEARCH | 2018年 / 6卷
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
MESENCHYMAL STEM-CELLS; IN-VITRO DEGRADATION; COMPOSITE SCAFFOLDS; GRAFT SUBSTITUTES; AUTOLOGOUS BONE; GROWTH-FACTORS; SHEAR-STRESS; REGENERATION; ENHANCEMENT; OSTEOBLASTS;
D O I
10.1038/s41413-018-0025-8
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Bone tissue engineering is an exciting approach to directly repair bone defects or engineer bone tissue for transplantation. Biomaterials play a pivotal role in providing a template and extracellular environment to support regenerative cells and promote tissue regeneration. A variety of signaling cues have been identified to regulate cellular activity, tissue development, and the healing process. Numerous studies and trials have shown the promise of tissue engineering, but successful translations of bone tissue engineering research into clinical applications have been limited, due in part to a lack of optimal delivery systems for these signals. Biomedical engineers are therefore highly motivated to develop biomimetic drug delivery systems, which benefit from mimicking signaling molecule release or presentation by the native extracellular matrix during development or the natural healing process. Engineered biomimetic drug delivery systems aim to provide control over the location, timing, and release kinetics of the signal molecules according to the drug's physiochemical properties and specific biological mechanisms. This article reviews biomimetic strategies in signaling delivery for bone tissue engineering, with a focus on delivery systems rather than specific molecules. Both fundamental considerations and specific design strategies are discussed with examples of recent research progress, demonstrating the significance and potential of biomimetic delivery systems for bone tissue engineering.
引用
收藏
页数:12
相关论文
共 56 条
  • [1] [Anonymous], 2016, Bone Grafts And Substitutes Market Size, Share Report, V2024, P80
  • [2] Mechanical properties of highly porous PDLLA/Bioglass® composite foams as scaffolds for bone tissue engineering
    Blaker, JJ
    Maquet, V
    Jérôme, R
    Boccaccini, AR
    Nazhat, SN
    [J]. ACTA BIOMATERIALIA, 2005, 1 (06) : 643 - 652
  • [3] Boden SD, 2001, SPINE, V26, P850, DOI 10.1097/00007632-200104150-00003
  • [4] Recent advances in bone tissue engineering scaffolds
    Bose, Susmita
    Roy, Mangal
    Bandyopadhyay, Amit
    [J]. TRENDS IN BIOTECHNOLOGY, 2012, 30 (10) : 546 - 554
  • [5] Cell-free and cell-based approaches for bone regeneration
    Bueno, Ericka M.
    Glowacki, Julie
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (12) : 685 - 697
  • [6] Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering
    Burdick, JA
    Anseth, KS
    [J]. BIOMATERIALS, 2002, 23 (22) : 4315 - 4323
  • [7] Acellular Biomaterials: An Evolving Alternative to Cell-Based Therapies
    Burdick, Jason A.
    Mauck, Robert L.
    Gorman, Joseph H., III
    Gorman, Robert C.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (176)
  • [8] Adult mesenchymal stem cells for tissue engineering versus regenerative medicine
    Caplan, Arnold I.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (02) : 341 - 347
  • [9] Effects of different fluid shear stress patterns on the in vitro degradation of poly(lactide-co-glycolide) acid membranes
    Chu, Zhaowei
    Li, Xiaoming
    Li, Ying
    Zheng, Quan
    Feng, Chenglong
    Guo, Meng
    Ding, Xili
    Feng, Wentao
    Gao, Yuanming
    Yao, Jie
    Chen, Xiaofang
    Wang, Lizhen
    Fan, Yubo
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2017, 105 (01) : 23 - 30
  • [10] Bone marrow stromal cells (BMSCs) in bone engineering: Limitations and recent advances
    Derubeis, AR
    Cancedda, R
    [J]. ANNALS OF BIOMEDICAL ENGINEERING, 2004, 32 (01) : 160 - 165